# Aopline Health Industry Technology (Guangzhou) Co., Ltd. – FDA Inspection, Nov 8, 2024

Source: https://www.keypedia.com/records/fda_inspections/aopline-health-industry-technology-guangzhou-co-ltd/6807a2a9-6d16-4f75-8489-e1012fdd0867
Source feed: FDA_Inspections

> FDA inspection 1255022 of Aopline Health Industry Technology (Guangzhou) Co., Ltd., November 08, 2024. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255022
- Company Name: Aopline Health Industry Technology (Guangzhou) Co., Ltd.
- Inspection Date: 2024-11-08
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Crystal Monroy](https://www.keypedia.com/people/crystal-monroy/b0414886-fb71-4f35-a453-0ad2baf13bfc)

Company: https://www.keypedia.com/companies/aopline-health-industry-technology-guangzhou-co-ltd/3ddd36ed-d61d-4fec-81a5-1cf7f0a5d525

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c